Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis
- 30 September 2002
- journal article
- clinical trial
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 89 (3), 298-303
- https://doi.org/10.1016/s1081-1206(10)61958-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitisOphthalmology, 2000
- Vernal keratoconjunctivitis revisited: A case series of 195 patients with long-term followupOphthalmology, 2000
- A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitisOphthalmology, 2000
- Tear levels of interferon‐γ, interleukin (IL) ‐2, IL‐4 and IL‐5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitisClinical & Experimental Allergy, 2000
- Classification of Ocular Atopic/Allergic Disorders and Conditions: an Unsolved ProblemActa Ophthalmologica Scandinavica, 1999
- Vernal KeratoconjunctivitisActa Ophthalmologica Scandinavica, 1999
- Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseasesJournal of Allergy and Clinical Immunology, 1998
- Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitisAllergy, 1995
- Topical Cyclosporine in Vernal KeratoconjunctivitisOphthalmology, 1991
- Clinical Trial of Topical Disodium Chromoglycate in Vernal KeratoconjunctivitisOphthalmologica, 1978